Join us on 23 October to discover how microbial antibiotic exposure triggers lipidomic changes, offering insight into how lipids contribute to resistance mechanisms.

Event details and registration

Register now

Antimicrobial resistance is an escalating global challenge, impacting both developed and developing countries and creating complex problems for scientists across disciplines. Escherichia coli (E. coli) is one such example, driving drug-resistant infections through its ability to adapt rapidly to environmental changes and acquire resistance to multiple drugs.

During this hour-long, interactive webinar, you’ll learn how LC-MS lipidomics reveals membrane remodelling during antibiotic stress and informs new therapeutic strategies. The speakers will explain how the Avanti Research™ SPLASH™ LIPIDOMIX™ Mass Spec Standard, part of the broader SPLASH™ portfolio, can be used for robust, reproducible lipid quantification, along with workflows for detecting strain-specific adaptations under ampicillin exposure.

This event will be of interest to biochemists, analytical chemists, and drug discovery researchers, particularly those familiar with lipidomics.

During this webinar, you will:

  • Learn about the wider context of antimicrobial resistance and drug discovery research
  • Gain practical insights for antimicrobial resistance research and diagnostic development
  • Develop a deeper understanding of SPLASH™ technology and how it can be integrated into your existing workflow

To aid accessibility, automatically generated closed captions, which can be turned on and off at your leisure, will be available to all those attending live. Please note, a certificate of attendance will be provided soon after the event. You do not need to request this – only those who attend the webinar live will be eligible.

Adriana Zardini Buzatto

Portrait of Adriana Zardini Buzatto

Adriana Zardini Buzatto is an assistant professor at the University of Calgary, Canada and associate director at the Calgary Metabolomics Research Facility (CMRF). She holds a Canada research chair in lipidomics and focuses on the analysis and characterisation of lipid molecules in biological systems. 

 

Amy Druschitz

Portrait of Amy Druschitz

Amy Druschitz is the technology development manager at Croda Pharma and leads the formulations division at Avanti Research™. She drives customer-focused innovation in lipid-based drug delivery systems, advancing new solutions for pharmaceutical applications.

Event details and registration

Register now